Eran Daniel Metzger, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delirium | 23 | 2024 | 1608 | 1.670 |
Why?
|
Long-Term Care | 2 | 2017 | 607 | 0.920 |
Why?
|
Group Processes | 1 | 2022 | 225 | 0.780 |
Why?
|
Advance Directives | 1 | 2022 | 245 | 0.720 |
Why?
|
Dementia | 7 | 2022 | 2501 | 0.700 |
Why?
|
Bulimia | 8 | 2008 | 381 | 0.640 |
Why?
|
Personal Autonomy | 2 | 2017 | 297 | 0.550 |
Why?
|
Nursing Homes | 5 | 2017 | 1034 | 0.500 |
Why?
|
Leadership | 1 | 2022 | 1357 | 0.440 |
Why?
|
Terminal Care | 1 | 2022 | 1688 | 0.360 |
Why?
|
Antipsychotic Agents | 5 | 2023 | 3058 | 0.320 |
Why?
|
Sexual Behavior | 1 | 2017 | 2050 | 0.300 |
Why?
|
Haloperidol | 4 | 2023 | 397 | 0.240 |
Why?
|
Ethics Committees, Clinical | 1 | 2003 | 56 | 0.220 |
Why?
|
Psychometrics | 6 | 2022 | 2999 | 0.210 |
Why?
|
Proxy | 1 | 2003 | 144 | 0.210 |
Why?
|
Loneliness | 1 | 2023 | 184 | 0.200 |
Why?
|
Postoperative Complications | 7 | 2021 | 15244 | 0.190 |
Why?
|
Homes for the Aged | 1 | 2003 | 260 | 0.190 |
Why?
|
Alzheimer Disease | 4 | 2024 | 7988 | 0.170 |
Why?
|
Amylases | 1 | 1999 | 172 | 0.170 |
Why?
|
Dexmedetomidine | 1 | 2023 | 315 | 0.170 |
Why?
|
Psychopharmacology | 1 | 2020 | 143 | 0.170 |
Why?
|
Truth Disclosure | 1 | 2003 | 435 | 0.160 |
Why?
|
Decision Making | 2 | 2022 | 3869 | 0.160 |
Why?
|
Frail Elderly | 1 | 2003 | 691 | 0.160 |
Why?
|
Salivary Glands | 1 | 1999 | 228 | 0.150 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 934 | 0.150 |
Why?
|
Video Recording | 1 | 2022 | 944 | 0.150 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2022 | 1953 | 0.150 |
Why?
|
Neuropsychological Tests | 3 | 2016 | 6974 | 0.140 |
Why?
|
Aged | 30 | 2024 | 162944 | 0.140 |
Why?
|
Benzodiazepines | 3 | 2023 | 1101 | 0.130 |
Why?
|
Geriatric Assessment | 2 | 2020 | 1369 | 0.130 |
Why?
|
C-Reactive Protein | 2 | 2017 | 3766 | 0.130 |
Why?
|
Aging | 5 | 2021 | 8626 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2021 | 6030 | 0.110 |
Why?
|
Humans | 49 | 2024 | 742088 | 0.110 |
Why?
|
Telephone | 1 | 2016 | 617 | 0.110 |
Why?
|
Leptin | 1 | 2000 | 1593 | 0.110 |
Why?
|
Antidepressive Agents | 3 | 2023 | 2838 | 0.110 |
Why?
|
Torsades de Pointes | 1 | 1993 | 78 | 0.100 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2749 | 0.100 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2021 | 1431 | 0.100 |
Why?
|
Anorexia Nervosa | 2 | 1997 | 1286 | 0.100 |
Why?
|
Pneumonia | 1 | 2022 | 2117 | 0.090 |
Why?
|
Psychomotor Agitation | 1 | 1993 | 288 | 0.090 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2575 | 0.090 |
Why?
|
Serotonin | 4 | 2000 | 1024 | 0.090 |
Why?
|
Hospitalization | 5 | 2022 | 10232 | 0.090 |
Why?
|
Risperidone | 2 | 2023 | 383 | 0.090 |
Why?
|
Accidental Falls | 1 | 2017 | 1057 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15530 | 0.090 |
Why?
|
Delphi Technique | 1 | 2012 | 778 | 0.090 |
Why?
|
Reproducibility of Results | 7 | 2022 | 19862 | 0.080 |
Why?
|
Aged, 80 and over | 12 | 2022 | 57683 | 0.080 |
Why?
|
Cognition Disorders | 2 | 2016 | 4030 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2022 | 3215 | 0.080 |
Why?
|
Long QT Syndrome | 1 | 1993 | 453 | 0.080 |
Why?
|
Female | 30 | 2023 | 379592 | 0.080 |
Why?
|
Caregivers | 1 | 2019 | 2074 | 0.080 |
Why?
|
Prospective Studies | 10 | 2023 | 53187 | 0.070 |
Why?
|
Convalescence | 1 | 2007 | 105 | 0.070 |
Why?
|
Family | 1 | 2017 | 3144 | 0.070 |
Why?
|
Tryptophan | 3 | 2000 | 478 | 0.070 |
Why?
|
Bulimia Nervosa | 1 | 2007 | 177 | 0.070 |
Why?
|
Hospitals | 3 | 2023 | 3937 | 0.060 |
Why?
|
Drug Utilization | 1 | 2010 | 1181 | 0.060 |
Why?
|
Algorithms | 3 | 2020 | 13853 | 0.060 |
Why?
|
Ethics, Institutional | 1 | 2003 | 37 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2010 | 2451 | 0.060 |
Why?
|
Fenfluramine | 2 | 2000 | 60 | 0.050 |
Why?
|
Ethics, Clinical | 1 | 2003 | 99 | 0.050 |
Why?
|
Depression | 1 | 2021 | 7733 | 0.050 |
Why?
|
Self Concept | 1 | 2008 | 1025 | 0.050 |
Why?
|
Friends | 1 | 2003 | 153 | 0.050 |
Why?
|
Cohort Studies | 5 | 2023 | 40450 | 0.050 |
Why?
|
Belgium | 1 | 2021 | 103 | 0.050 |
Why?
|
Amino Acids | 2 | 2000 | 1727 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13921 | 0.050 |
Why?
|
Mass Screening | 4 | 2022 | 5238 | 0.050 |
Why?
|
Male | 17 | 2023 | 349538 | 0.050 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2001 | 113 | 0.050 |
Why?
|
Prolactin | 2 | 2000 | 669 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14720 | 0.050 |
Why?
|
Brain Diseases | 1 | 2010 | 1554 | 0.050 |
Why?
|
Follicular Phase | 1 | 2000 | 153 | 0.050 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2019 | 108 | 0.040 |
Why?
|
Serotonin Receptor Agonists | 1 | 2000 | 154 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2023 | 5310 | 0.040 |
Why?
|
Cognition | 3 | 2022 | 6722 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2021 | 21719 | 0.040 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2007 | 1442 | 0.040 |
Why?
|
Citalopram | 1 | 2020 | 404 | 0.040 |
Why?
|
Psychotropic Drugs | 1 | 2023 | 893 | 0.040 |
Why?
|
Professional-Patient Relations | 1 | 2003 | 736 | 0.040 |
Why?
|
Receptors, Serotonin | 1 | 1997 | 210 | 0.030 |
Why?
|
Consensus | 2 | 2017 | 2935 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 2020 | 472 | 0.030 |
Why?
|
Boston | 2 | 2012 | 9305 | 0.030 |
Why?
|
Cardiac Surgical Procedures | 1 | 2010 | 3526 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2023 | 1158 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6294 | 0.030 |
Why?
|
Incidence | 3 | 2017 | 20928 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.030 |
Why?
|
tau Proteins | 1 | 2024 | 1860 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2414 | 0.030 |
Why?
|
Mental Disorders | 2 | 2010 | 6587 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 77098 | 0.030 |
Why?
|
Patient Participation | 1 | 2003 | 1445 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2023 | 1914 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2203 | 0.030 |
Why?
|
Confusion | 1 | 2014 | 275 | 0.030 |
Why?
|
Body Weight | 2 | 2000 | 4664 | 0.030 |
Why?
|
Metabolomics | 1 | 2021 | 1467 | 0.030 |
Why?
|
Lung Diseases, Obstructive | 1 | 1993 | 316 | 0.030 |
Why?
|
Body Composition | 1 | 2000 | 2400 | 0.020 |
Why?
|
Outpatients | 1 | 2019 | 1483 | 0.020 |
Why?
|
Risk Factors | 4 | 2022 | 72145 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2024 | 3574 | 0.020 |
Why?
|
Observation | 1 | 2012 | 312 | 0.020 |
Why?
|
Prevalence | 3 | 2019 | 15194 | 0.020 |
Why?
|
Risk Assessment | 3 | 2017 | 23320 | 0.020 |
Why?
|
United States | 4 | 2023 | 69693 | 0.020 |
Why?
|
Eating | 1 | 1997 | 1535 | 0.020 |
Why?
|
Psychological Tests | 1 | 2012 | 648 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 2997 | 0.020 |
Why?
|
Linear Models | 1 | 1999 | 5948 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3862 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3387 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29010 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3518 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3548 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1993 | 2271 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 975 | 0.020 |
Why?
|
Adult | 10 | 2008 | 213712 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2014 | 2536 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 1993 | 859 | 0.020 |
Why?
|
Cardiomyopathy, Dilated | 1 | 1993 | 851 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2012 | 968 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8662 | 0.020 |
Why?
|
Ultrasonography | 1 | 1999 | 5978 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13403 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10372 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1997 | 10943 | 0.020 |
Why?
|
Placebos | 2 | 2000 | 1677 | 0.010 |
Why?
|
Qualitative Research | 1 | 2012 | 2680 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10392 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8328 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3618 | 0.010 |
Why?
|
Alcoholism | 1 | 1993 | 1904 | 0.010 |
Why?
|
Patient Care Team | 1 | 1993 | 2527 | 0.010 |
Why?
|
Quality of Life | 1 | 2003 | 12730 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1418 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2010 | 2281 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13256 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18355 | 0.010 |
Why?
|
Electrocardiography | 1 | 1993 | 6440 | 0.010 |
Why?
|
Diet | 1 | 1997 | 7923 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39004 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1997 | 326 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 24913 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7716 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12958 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 5979 | 0.010 |
Why?
|
Hormones | 1 | 2000 | 884 | 0.010 |
Why?
|
Models, Statistical | 1 | 2010 | 5100 | 0.010 |
Why?
|
Hemoglobins | 1 | 2001 | 1532 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 62966 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1997 | 1589 | 0.010 |
Why?
|
Middle Aged | 3 | 2010 | 213127 | 0.010 |
Why?
|
Reference Values | 1 | 2000 | 4982 | 0.010 |
Why?
|
Brain | 1 | 1997 | 26343 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1995 | 2030 | 0.010 |
Why?
|
Body Mass Index | 1 | 2007 | 12695 | 0.010 |
Why?
|
Nutritional Status | 1 | 1997 | 1606 | 0.010 |
Why?
|
Health Status | 1 | 2001 | 4030 | 0.000 |
Why?
|
Pilot Projects | 1 | 1995 | 8297 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1995 | 12017 | 0.000 |
Why?
|
Adolescent | 1 | 1995 | 85649 | 0.000 |
Why?
|